The role of IL-12 and IL-23 signaling in the development of IBD is highlighted by the fact that patients with complete loss-of-function mutations in IL23R, IL12RB1, or IL12B do not develop spontaneous inflammatory bowel disease [108]. The gene discussed is IL37; the disease is inflammatory bowel disease.